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Abstract
Risky behaviors, such as substance use and unprotected sex, are associated with vari-
ous physical and mental health problems. Recent genome-wide association studies
indicated that variation in the cell adhesion molecule 2 (CADM2) gene plays a role in
risky behaviors and self-control. In this phenome-wide scan for risky behavior, it was
tested if underlying common vulnerability could be (partly) explained by pleiotropic
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effects of this gene and how large the effects were. Single nucleotide polymorphism
(SNP)-level and gene-level association tests within four samples (25 and Up, Spit for
Science, Netherlands Twin Register, and UK Biobank and meta-analyses over all sam-
ples (combined sample of 362,018 participants) were conducted to test associations
between CADM2, substance- and sex-related risk behaviors, and various measures
related to self-control. We found significant associations between the CADM2 gene,
various risky behaviors, and different measures of self-control. The largest effect sizes
were found for cannabis use, sensation seeking, and disinhibition. Effect sizes ranged
from 0.01% to 0.26% for single top SNPs and from 0.07% to 3.02% for independent
top SNPs together, with sufficient power observed only in the larger samples and
meta-analyses. In the largest cohort, we found indications that risk-taking proneness
mediated the association between CADM2 and latent factors for lifetime smoking
and regular alcohol use. This study extends earlier findings that CADM2 plays a role in
risky behaviors and self-control. It also provides insight into gene-level effect sizes
and demonstrates the feasibility of testing mediation. These findings present a good
starting point for investigating biological etiological pathways underlying risky
behaviors.
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1 | INTRODUCTION
Risky behaviors, such as substance use (e.g., nicotine, alcohol, and
cannabis) and unprotected sexual contact, are important factors con-
tributing to physical and mental health problems.2 As a result, these
risk factors for morbidity and mortality3 are included in the global
Sustainable Development Goals, set up and agreed on by all member
states of the United Nations in 2015 to ensure more healthy lives
and promote quality of life worldwide.4 For instance, substance use
contributes to approximately 12% of deaths worldwide,5 due to fac-
tors such as an increased risk of respiratory and vascular diseases,
various forms of cancer, stroke, suicide, or overdose.6 Approximately
4% of the global burden of disease, as measured in disability-adjusted
life years (DALYs),7 is attributable to alcohol and tobacco use and
0.8% to illicit drugs.5 Furthermore, risky sexual behavior
(e.g., unprotected sexual intercourse with multiple partners) contrib-
utes another 6.3% of the total global burden of disease, as it is asso-
ciated with the risk of sexually transmitted infections (STIs), human
immunodeficiency virus (HIV), or cervical cancer.6,8
Various studies indicate that risky behavior has a substantial
genetic component. For instance, a substantial part of the variation in
the initiation of substance use can be explained by genetic factors:
alcohol (37%),9 nicotine (44%),10 and cannabis (40%–48%).11 Even
higher heritability estimates are shown for substance use disorders,
for example, alcohol: 45%–73%,9,12 nicotine: 44%–75%,9,10,12 and
cannabis: 37%–59%.11,12 Furthermore, the heritability of risky sexual
behavior was estimated by previous research to be around 33%.13 It
is assumed that different risky behaviors might merely reflect
different phenotypic manifestations of (partly) shared underlying
genetic vulnerabilities.14,15 However, it is largely unknown which
genetic and biological mechanisms underpin the heritability of risky
behaviors.16
Recent large genome-wide association studies (GWASs) have
independently implicated a gene located on chromosome 3 encoding
cell adhesion molecule 2 (CADM2) in various risky behaviors including
alcohol (ab)use,17 lifetime cannabis use,1 number of sexual partners,17
and age at first sexual intercourse.18 Proteins encoded by CADM2 are
involved in glutamate signaling, GABA transport, and neuron cell–cell
adhesion, especially in the prefrontal and anterior cingulate cortices.19
These brain regions are well known for their role in cognitive control
and motivational salience, which are in turn involved in impulse regu-
lation and self-control.20,21
Low self-control, as indexed by high impulsivity, sensation seek-
ing, and disinhibition, has been associated with engaging in risky
behavior, including unprotected sexual intercourse13 and substance
use (initiation) or abuse.22,23 A review by Bezdjian et al. showed heri-
tability for different indices of self-control of around 50% across
41 studies including around 27,000 infants, children, adolescents,
and adults.24 These findings suggest that genetic factors, at least in
part, modulate various aspects of self-control. Specifically, CADM2
has been associated with sensation seeking,23 hyperactivity, and
impulsivity.25 This suggests potential shared heritability between
reduced self-control and risky behavior, most likely due to over-
lapping underlying biological processes.13,22,23 As such, reduced self-
control might act as intermediate phenotype, linking CADM2 and
various risky behaviors.
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Candidate-gene studies have traditionally selected plausible
candidate-genes based on a theory on the underlying biological mech-
anisms, for example, relating the dopamine cascade to ADHD26 or
substance use.27 This approach is limited by current knowledge of the
biology of investigated behaviors.27 In addition, candidate-gene stud-
ies are often restricted by a lack of available data resulting in under-
powered or small-scale designs28 and examination of only a few (or a
single) phenotype(s).29 Consequently, these limitations have rendered
the candidate-approach largely unsuccessful.30,31
We propose to apply GWAS techniques on a single gene,
whose candidate-gene status is anchored in a body of (hypothesis-
free) GWASs. In this first phenome-wide association study
(PHeWAS)32 for CADM2 and risky behavior, the multiple testing
burden is much lower than in GWASs, which should increase power.
This study aims to establish if power increases substantially enough
to detect associations in smaller samples, thereby also providing
insight into gene-level effect sizes. By looking at several risky
behavior phenotypes concurrently, we furthermore investigate the
link between genetic variation in CADM2 and substance- and sex-
related risk behaviors more comprehensively than single phenotype
studies. Doing so, we aim to examine if the involvement of CADM2
in various risky behaviors and self-control related constructs
(i.e., pleiotropy, when a single gene influences the expression of
multiple phenotypic traits) can explain the potential genetic overlap
between various aspects of reduced self-control and multiple risky
behaviors. By combining data from four different cohorts and ana-
lyzing a range of risky behaviors and indices of self-control, we aim
to increase reliability and robustness of findings.29 Finally, we
explore if reduced self-control might mediate the relationship
between CADM2 and various risky behaviors.
In data across four European ancestry population-based samples
from different countries, we tested here whether single nucleotide
polymorphisms (SNPs) in CADM2 are associated with risk behavior,
including (1) substance use and abuse (alcohol, tobacco, cannabis, and
other drugs), (2) sexual risk behavior (number of sex partners, sexual
risk-taking, and age at first sexual intercourse), and (3) indices of
reduced self-control (disinhibition, sensation seeking, risk-taking
proneness, and ADHD symptoms). We conduct factor analyses to
explore common underlying vulnerability factors. Furthermore, we
explore whether relationships between CADM2 and risk behaviors are
mediated by a self-control trait.
2 | MATERIALS AND METHODS
2.1 | Subjects and procedures
Data from 443,693 participants from four different data sources were
used, including the Queensland Twin Registry's “25 and Up” (25Up:
N = 2,133) study in Australia,33 “Spit for Science” (S4S: N = 2,994)
study in the USA,34 the “Netherlands Twin Register” (NTR:
N = 12,120) repository in The Netherlands,35 and the “UK Biobank”
(UKB: N = 426,446) in the United Kingdom.36 Although 25UP and
S4S are considerably smaller than the others, they have not been
included in previous risk behavior GWAS and have data on pheno-
types that were not available in NTR and UKB, making them valuable
additions. All studies were performed in accordance with the Declara-
tion of Helsinki and were approved by local ethical committees. Study
details are described in articles referenced in the Supplementary
Methods section.
2.2 | Measures
2.2.1 | Genotyping and quality control
We used available genotyped or imputed SNP information in and
around CADM2 (chr 3 (3p12.1), bp 83,951,945-86,126,470,
GRCh37/hg19). Per sample genotyping, imputation and quality con-
trol (QC) procedures can be found in Table S1. Variants with a minor
allele frequency (MAF) below 1%, a genotype missingness rate above
5%, or deviations from Hardy–Weinberg Equilibrium (HWE) of
p < 1e-10 were excluded from further analysis. SNPs were aligned
with the 1,000 Genomes reference panel (phase 3),37 removing
ambiguous SNPs and SNPs that had a MAF that diverged more than
0.15 from that in the reference panel. Following these procedures,
n25Up = 297, nS4S = 2,972, nNTR = 6,166, and nUKB = 4,638 SNPs were
available and retained for analysis. Genetic data and data on at least
one phenotype were available for N25Up = 2,133, NS4S = 2,994,
NNTR = 12,120, and NUKB = 426,446 individuals (total N = 443,693).
The per-phenotype sample size range was N25Up = 419–2,071,
NS4S = 503–2,384, NNTR = 581–9,432, and NUKB = 23,423–362,018
individuals.
2.2.2 | Outcome measures
In this study, we adopted a PHeWAS approach, meaning that we
tested the association between CADM2 and all risk behavior and
self-control measures that were available in the datasets. In order
to provide an overview of all measures, we grouped them into six
categories: lifetime experience with substance use (regarding
tobacco, cannabis, and other substances), age at initiation of sub-
stance use (regarding alcohol, tobacco, cannabis, and other sub-
stances), average substance use level (regarding alcohol and
tobacco), regular substance (ab)use (including regular alcohol,
tobacco, and cannabis use and any behavioral/substance addiction),
sexual risk behavior (including the number of sexual partners, sexual
risk-taking, and age at first sexual intercourse), and self-control
(including disinhibition, sensation seeking, risk-taking proneness, and
symptoms of ADHD). Variables with a total N of < 1,000 were
excluded as they could not be analyzed due to a lack of statistical
power. Preprocessing of the data included combining measures
(e.g., across different waves), removing outliers, and excluding
inconsistent or invalid response patterns. An overview of all 23 out-
come measures included can be found in Table 1. More detailed
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information about the (cleaning and combining of the) measures is
given in Table S2.
2.3 | Data analysis
Primary analyses were performed separately within each cohort and
combined in meta-analyses. Identical analysis procedures were used
in all individual datasets. Phenotype data cleaning, preparation, and
descriptive analyses were conducted using the Statistical Package for
the Social Sciences (SPSS; version 25).38
To test whether CADM2 SNPs were associated with separate risk
behavior outcomes, association analyses were firstly conducted in
PLINK (version 1.9).39 For dichotomous phenotypes, logistic regres-
sion was used; for continuous variables, we used linear regression.
Covariates included sex, age, and highest level of education, as we
aimed to capture the influence of CADM2 on risk behavior and self-
control that was independent of these factors (e.g., education has
shown to be associated both with CADM2 and risk behavior).40 Fur-
thermore, principal components (PCs) for ancestry were included. PCs
are used to control for possible stratification effects that arise when a
genetic factor and a trait show a spurious correlation due to system-
atic differences in allele frequencies between groups of different
genetic ancestry. We used the PCs as calculated by the institute we
received the data from, following their recommendations on how
many PCs were appropriate to control for ancestry stratification
effects within their specific sample. Because S4S participants were
recruited at university, parental rather than own education level was
included as a covariate in this sample. In 25Up, S4S, and NTR we used
10 PCs to control for population stratification, while in UKB we
included 40 PCs. We controlled for clustering due to genetic related-
ness in the twin datasets (25Up and NTR) by using the family option
in PLINK and excluded individuals that showed high genetic related-
ness in the other datasets (see Table S1).
Second, to assess the overall effect of the variants at the gene
level, the association results were analyzed using Multi-marker Analy-
sis of GenoMic Annotation gene-based tests (MAGMA, version 2).41
Because not all phenotypes were present in all cohorts, we conducted
these analyses separately per cohort. SNPs were mapped to CADM2
using 1000Genomes phase 3 data. We used the snp-wise = top
procedure, which is more sensitive when only a small proportion of
SNPs in the gene shows an association. To control for the number of
phenotypes tested, we computed the Benjamini–Hochberg False
Discovery Rate (FDR)42 p-values within each variable category,
using R (version 3.6.2).43 When reporting the results, we present
uncorrected p-values with an asterisk indicating if the FDR-corrected
p-value was below p = .05.
Thirdly, we conducted two meta-analyses for those phenotypes
that were present in multiple datasets in order to maximize power to
detect associations. The first meta-analysis was performed on the
results from the per-cohort gene-based tests using the meta-analysis
procedure in MAGMA. This method aggregates the Z-values for the



































































































































































































































































































































































































































































































































































































































































































































































ARENDS ET AL. 5 of 13
sample size into account, in a procedure similar to “normal” meta-
analysis. The results give an indication of the strength of the associa-
tion with CADM2 across cohorts. The second meta-analysis was used
to get per-SNP effects that can be used to estimate the variance in
the phenotype explained by SNPs in the gene (R2). To conduct these
meta-analyses, odds ratios for binary outcome variables were
converted to betas with corresponding standard errors in the input
files and all continuous variables were standardized. The meta-analysis
was conducted in METAL44 based on standard errors and effect esti-
mates (rather than on sample size) so that β and se(β) could be
obtained.
Using the results from the SNP-based meta-analysis, we com-
puted R2 (the procedure is described in Supplementary Methods II).
To give an indication of how the resulting effect size estimates
impacted power, we conducted post-hoc power analyses for the
meta-analysis. The analysis was conducted based on the observed
effect sizes as a function of the minimum and maximum sample size.
We used the compromise power analysis option from the G*power
package for the F test family with a single predictor.45
2.3.1 | Mediation analysis with latent factors
A secondary aim of this study was to test whether the association
between CADM2 and risky behavior would be mediated by one or
more indices of self-control. Assuming that latent factors would be
stronger measures of underlying risky behavior propensity than the
separate phenotypes (and to limit the number of analyses), we used
factor scores in the mediation analyses. Assuming that CADM2 is
associated with risky behavior and reduced self-control in general
rather than specific behaviors or constructs per se, such latent fac-
tors might show stronger relationships with CADM2. We used a
data-driven approach without a priori specifying the nature of the
factors or the number of factors to extract. We expect clustering due
to the overlap in the measures, but the actual clustering could differ
per sample. We used PC analysis with principal axis factoring
(PAF/PFA) including oblique (oblimin) rotation; missing values were
replaced with the mean.46 The analyses were conducted separately
for each cohort and factors with an Eigenvalue >1 that explained
>10% of the variance were extracted from the dataset (see
Table S3). Subsequently, individual factor scores were computed
using regression.
To test if a self-control trait can explain the association between
CADM2 and risky behavior, we tested mediation following Baron and
Kenny's procedure (see Figure 1, including p-values rather than
regression weights as MAGMA does not provide such estimates).47
We first tested the relationship between CADM2 and the risk behav-
ior factor (path c) in MAGMA, and if that was significant, we tested
the association between the self-control trait (mediator) and the risk
behavior factor in SPSS (path b). If path b and path c were significant,
and there was an association between a self-control trait and CADM2
in the gene-based test (path a), we tested in a final step the relation-
ship between CADM2 and the risk behavior factor outcome, while
controlling for the self-control mediator, in MAGMA (path c'). When
in path c' the relationship between the risk behavior and CADM2 was
attenuated while controlling for self-control, mediation was
assumed.48 In all paths, we controlled for the effects of age, sex, and
education, and in the analyses involving genetic data, we controlled
for the PCs.
As an addition to see if common propensity would indeed show a
stronger association with CADM2, we also meta-analyzed factors that
were made up of similar indicators in different cohorts. We used simi-
lar procedures for these analyses as for the separate phenotypes in
MAGMA.
F IGURE 1 Significance of associations between CADM2 and risk behavior factors, with and without a mediating effect of risk-taking
proneness. Path a: the effect of the predictor (CADM2) on the mediator (risk-taking proneness); path b: the effect of the mediator on the outcome
factors (tobacco (ab)use, lifetime smoking, and risky alcohol use); path c: the effect of the predictor on the outcome variables; path c': the effect of
the predictor on the outcome variables controlling for the mediator. † C0 paths with attenuated p-values, indicating a partial mediation effect
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3 | RESULTS
3.1 | Demographics and descriptives
The sample size of people included in at least one analysis consisted of
443,693 individuals (maximum sample size per analysis N = 362,018).
Slightly more than half of the participants (54%) were female (25Up:
61%, S4S: 58%, NTR: 62%, UKB: 54%), and age ranged from 18 to
94 with a weighted mean age of 38 years (25Up: M = 30.1, SD = 4.3;
S4S: M = 20.7, SD = 1.5; NTR: M = 44.8, SD = 16.9; UKB: M = 54.7,
SD = 8.0). Furthermore, most participants had a moderate (49%) or
high (33%) level of education (largest group 25Up: 41.7% moderately
high, S4S: 77.5% high, NTR: 45.7% high, UKB: 32.4% high education).
Cohort descriptions are provided in Table 1, including a descrip-
tion of the mean (continuous variables) and prevalence rates (dichoto-
mous variables) for all outcome measures. Due to different
operationalizations and sample compositions in the four cohorts, most
descriptives cannot be directly compared. In the association analyses,
we controlled for age, sex, and education level, and we conducted
meta-analysis either on per-sample Z-scores for the association
(in MAGMA) or on standardized regression weights (in METAL) to
control for sample differences.
3.2 | Associations for CADM2 with risk behavior
and self-control
The associations between CADM2 and risk behavior and indices of
self-control are shown in Table 2. Associations that were significant
after FDR-correction for multiple testing (at p < .05) are indicated with
an asterisk. Both lifetime tobacco use and lifetime cannabis use were
associated with CADM2 in the meta-analyses. In the individual sam-
ples, these associations were significant in NTR and UKB but not in
25Up and S4S. No significant associations were found for lifetime use
of other substances (i.e., recreational drugs), although it must be noted
that this variable was not present in the largest sample (UKB). None
of the age at initiation of substance use variables were associated
with CADM2. The smallest p-value was.049 in the NTR sample for age
at alcohol initiation. After correction for multiple testing, this finding
was no longer significant. The meta-analyses revealed associations
between both average alcohol consumption and average number of
cigarettes per day and CADM2 that seem to be largely driven by sig-
nificant associations in the UKB sample. Regular alcohol use, problem-
atic alcohol use, regular tobacco use, and nicotine dependence were
all associated with CADM2 in the meta-analyses. In the individual
study analyses, only regular alcohol use was after correction signifi-
cantly associated with CADM2 in a sample (S4S) other than the UKB.
The number of sexual partners was associated with CADM2 in 25Up,
UKB and the meta-analysis, and age at first sexual intercourse in UKB
and the meta-analysis but not in the individual 25Up, S4S, or NTR
samples.
As for the analyses of indices of self-control, a significant associa-
tion between CADM2 and disinhibition (significant in the NTR and
meta-analysis), sensation seeking (in NTR), and risk-taking personality
(in UKB) was observed. As the constructs of sensation seeking and
risk-taking personality were only measured in one study, no meta-
analyses could be performed.
SNP-based meta-analyses were conducted in order to get per-
SNP estimates that could be used to compute explained variances.
Results show little overlap between the top-SNPs for different pheno-
types (see Table S4). Only 31 SNPs showed a significant association
with multiple independent phenotypes.
3.2.1 | Effect sizes of the associations and power
analyses
The variance explained by all independently associated SNPs in
CADM2 taken together ranged from 0.07% for regular alcohol use to
3.02% for regular cannabis use (M = 1.05%, SD = 1.09%,
Mdn = 0.45%). The sample sizes included in the analyses ranged from
2,094 to 362,018 individuals (see Table 2). It does not seem to be the
case that phenotypes from a particular sample or specific category
have higher R2 than the others. Also, there does not seem to be an
effect of the number of SNPs in the analysis on the size of R2
(r = −0.27, p > 0.05).
As most effect sizes were below 1%, we set the power analysis
parameters at R2 = 0.001% to 1% as a range for the effect size and
2,000–400,000 as a range for the sample size. For an effect size of
0.001% even a sample size of 400,000 results in a power level of only
50%, whereas for an effect size of 1% a sample size of 8,000 suffices
to achieve 80% power. In our study, the average observed effect size
of the top SNP was R2 = 0.11%, resulting in sufficient (>80%) power
levels at sample sizes of at least N = 7,100. A visualization of power as
a function of effect size and the SNP sample size are provided in
Figure S1A,B.
3.2.2 | Mediation analysis with latent factors
Factor analysis of the 14–20 outcomes per sample overall identified
five factors with Eigenvalues above 1 and explained variance >10%,
of which two appeared to be made up by similar variables in multiple
cohorts (see Table S3). The latent factor lifetime substance use was
present in 25Up and S4S and was not significantly associated with
CADM2. A tobacco (ab)use factor could be discerned in all datasets
but was only significantly associated with CADM2 in UKB with
p = 8.45e-06. In UKB there were two other factors, one for lifetime
smoking and one for regular alcohol use, which were both associated
with CADM2 (p = 1.01e-22 and p = 5.84e-13, respectively). Finally, in
NTR there was a self-control factor that was associated with CADM2
(p = 2.28e-08).
Thus, there were three risk behavior factors that could be used
for the mediation analyses, all extracted from the UKB. There was
only one measure of self-control included in the UKB, namely, risk-
taking proneness (yes/no). Results of the analysis using this measure
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as a mediator between CADM2 and the three risk-taking behavior
factors are presented in Figure 1 (with p-values rather than regres-
sion weights as MAGMA does not provide such estimates). Path
a for the association between CADM2 and risk-taking proneness con-
trolling for sex, age, and PCs was tested earlier and found to be sig-
nificant (see Table 2). Paths c1–c3 for the associations between
CADM2 and the outcomes (risk behavior factors) were reported in
Table 3. Paths b1–b3 between risk-taking proneness and the risk
behavior factors were all significant (tobacco [ab]use factor OR = 1.27,
p < .001; lifetime smoking factor, OR = 1.27, p < .001; and alcohol
abuse factor OR = 1.21, p < .001). In step c0 , the associations
between CADM2 and lifetime smoking and risky alcohol use factors
were attenuated when including the mediator (p = 1.01e-22 to
1.51e-18 and 5.84e-13 to 5.05e-09, respectively), suggesting partial
mediation by risk-taking proneness. The association between tobacco
(ab)use and CADM2 was enhanced (p = 4.34e-05 to 9.14e-07) when
controlling for risk-taking proneness, which suggests that there was
no mediation effect.
4 | DISCUSSION
In this multi-cohort study, it was shown that CADM2 is associated
with multiple substance use and abuse traits, sex-related risky behav-
ior, and different indices of self-control. Meta-analyses showed signif-
icant associations between CADM2 and lifetime experience with
tobacco and cannabis use, average alcohol and cigarette consumption,
regular/problematic alcohol and tobacco use, number of sexual part-
ners, age at first sexual intercourse, and disinhibition. Furthermore, in
the per-sample analyses there were significant associations with sen-
sation seeking, behavioral or substance addiction, and risk-taking
proneness. The variance explained by a single CADM2 SNP ranged
from 0.01% (for average alcohol consumption, cigarettes per day, nic-
otine dependence, and the number of sexual partners) to 0.26%
(sensation seeking). Independent top SNPs together explained
between 0.07% (regular alcohol use) and 3.02% (regular cannabis use)
of the variance. Finally, the self-control trait “risk-taking proneness”
was found to be a significant partial mediator of the associations
between CADM2 and latent factors for lifetime smoking and regular
alcohol use.
The results of this study are in line with results from recent
GWAS, indicating associations of CADM2 with substance use and
abuse (including alcohol consumption, lifetime cannabis use, and gen-
eral drug experimentation),1,17,23,49 sexual risk behavior (such as age
at first sexual intercourse and number of sexual partners),17,28 and dif-
ferent aspects of self-control (sensation seeking, hyperactivity, and
risk-taking propensity).1,18,23,25 Our study finds support for these find-
ings in a large, hypothesis-driven, multi-cohort and phenome-wide
study for risk behavior, indicating that the role of CADM2 in risky
behaviors and reduced self-control is robust. This is also in line with
some earlier reported genetic correlations for various forms of risky
behaviors,40 suggesting overlapping genes directly or indirectly influ-
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proneness is in line with previous suggestions that the association
between substance use and CADM2 might be (partially) mediated by
reduced self-control.49 Our results suggest that variability in CADM2
may give rise to various aspects of reduced self-control underlying
multiple expressions of risky behavior. This corresponds with pro-
posed shared genetic and neurobiological mechanisms underlying var-
ious risky behaviors.14,15
CADM2 is mainly expressed in the brain (predominantly prefrontal
and anterior cingulate cortices [PFC and ACC]), the central nervous
system, and its peripheral nerve fibers.23,50 The PFC and ACC are gen-
erally involved in cognitive functions concerned with motivation and
controlling behavior.51 The ACC has been associated with error detec-
tion and response inhibition, whereas several regions within the PFC
are involved in reward learning and decision-making processes, which
can all be linked to self-control and risky behavior.52–54 By affecting
brain functions in these regions, variation in CADM2 may result in dif-
ferent manifestations of reduced self-control and risky behavior.
Future research could further delineate which neurobiological mecha-
nisms are involved in the link between CADM2, reduced self-control,
and risky behaviors.
Looking at the individual SNPs (see Table S4), we observe that
most top SNPs cluster in the region roughly around 85,500,000 (see
Figure S2). This is a region containing large numbers of expression
quantitative trait loci (eQTLs; panel C). eQTLs are places in the
genome that influence to what extent a gene comes to expression,
that is, how much is transcribed to messenger RNA. Only a few SNPs
are among the top 10 independent SNPs for more than one pheno-
type. This suggests that the effects of CADM2 were not driven by one
strong causal SNP. Six SNPs were associated with three different
(but overlapping) primary phenotypes (sensation seeking, any
behavioral/substance addiction, and risk-taking proneness). Another
SNP that was a top SNP more than twice was rs1271459, associated
with ever tobacco use, regular tobacco use, and age at first sexual
intercourse. SNPs associated with multiple distinct phenotypes might
be more central to the functioning of the gene. As an illustration, we
looked up this rs1271459. No information was available for this SNP
itself, but its proxy rs9820373 is a significant eQTL for CADM2
expression in the subcutaneous adipose tissue (pfdr = 5.4E-4).
55 This is
interesting as CADM2 has been associated with BMI,56 potentially
through impulsive over-eating.
4.1 | Strengths and limitations
This study has to be viewed in light of its strengths and limitations.
Data from separate cohorts with different characteristics were used,
which results in a large sample size and high generalizability. It also
induces measure heterogeneity, which on the one hand may have lim-
ited the power to detect effects in the meta-analyses and on the other
hand further substantiates the robustness of findings. This study
included a range of risky behavior and self-control phenotypes, poten-
tially expanding the findings. Furthermore, previous research also indi-
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risk-taking behaviors and personality.1,23 Future studies might further
explore the role of CADM2 in other potentially related phenotypes,
such as (a lack of) physical activity, eating patterns or overweight,
gambling, and reckless driving2 and should investigate if these results
generalize to populations with different age ranges or different
genetic ancestry.
In this study, we observed explained variances between 0.01%
and 3.02%. The 25UP and S4S samples were too small to detect sig-
nificant effects in the individual samples. Virtually all phenotypes
reached significance only after adding data from the larger samples
(NTR and UKB). The comparison of four cohorts with different sample
sizes has shown that in general samples of over 7,000 individuals are
needed to find significant effects with these effect sizes (see
Figure S1).45,49 This means that for the phenotypes that were avail-
able in UK Biobank, the addition of the other samples has not led to a
substantial increase in information over and above what we already
learned from previous studies. This is the first study to our knowledge,
using this method to give a concrete indication of what sample sizes
are needed to detect the effect of a single gene. We may conclude
that we must be cautious to draw conclusions from individual
small samples, but that these smaller samples can be combined in
meta-analyses, especially for (possibly more detailed) phenotypes that
are not available in large-scale data sets.
This is the first study aiming to shed light on effect sizes that can
be expected on the level of genes. Although small, these effects are
substantially larger than those of single variants, as have traditionally
been investigated in candidate-gene research. Also, given that behav-
ior arises as a result of a complex interplay between environment and
a large number of genes with small effects, the effect sizes of CADM2
that we find could actually be considered substantial. Looking at the
level of genes rather than SNPs is biologically more meaningful and
could provide clues on underlying biological mechanisms, which in
turn will contribute to a better understanding of transgenerational
transmission of risky behaviors and provide clues for designing treat-
ment and prevention programs.
This study shows the feasibility and added value of novel varia-
tions of the more common analyses in the field of behavior genetics,
including genetic association analyses on factor analyzed traits and
mediation analyses. New questions might be answered using such
techniques, providing more insight into underlying common vulnera-
bility patterns and etiological mechanisms. However, there were
some limitations to the mediation analyses, including the lack of con-
trol for family relatedness and covariates in the Principal Compo-
nents Analyses and the impossibility of calculating regression weights
for the associations with CADM2. Also, we used Baron and Kenny's
procedure to test for mediation only for outcomes that showed a sig-
nificant relationship with CADM2.47 Technically, mediation could
arise in the absence of such a relationship. Bootstrapping is a more
recently developed non-parametric method that can increase power
to detect mediation. However, this approach has not yet been
implemented in the area of genetic association analysis. Future
research might develop techniques to tackle these limitations. In con-
clusion, the mediation results in this study suggest that mediation
testing may be feasible, but improved statistical tools applicable to
behavioral genetics need to be developed.
Next to the genetic etiology of risk behaviors, we recognize the
generally known influence of environmental factors.13 For example
cultural, parenting or peer norms can influence substance- and sex-
related risky behaviors. What remains largely unknown is to what
extent the impact of genetic and environmental risks is additive or
interactive. The variants in CADM2 identified here lend themselves
well to future gene–environment interaction testing, provided a multi-
cohort study and a combined SNP measure are used to ensure suffi-
cient power.
5 | CONCLUSIONS
This comprehensive multi-cohort study has shown the feasibility of a
PHeWAS for risky behavior to confirm previous findings on associa-
tions between CADM2 and manifestations of risky behavior and
reduced self-control from GWASs on individual phenotypes. It was
shown that single SNPs in CADM2 could explain 0.01% to 0.26% of
the variance and a combination of independent top SNPs together
0.07% to 3.02%. This study provides more insight into the relatively
small effect sizes that can be expected from association studies. Fur-
thermore, results revealed that a self-control trait might partially
mediate the associations between CADM2 and substance-related risky
behavior (lifetime smoking and regular alcohol use). Future studies
should further explore the biological underpinnings of the observed
relationships between CADM2, reduced self-control, and various risky
behaviors.
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